Vaxcyte, Inc. PCVX Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$766.63M-65.2% | -$463.93M-15.3% | -$402.27M-80.0% | -$223.49M-123% | ||
| $16.4M+134% | $7M+122% | $3.16M+11.4% | $2.83M+57.4% | ||
| $138.85M+63.7% | $84.82M+74.0% | $48.76M+106% | $23.65M+120% | ||
| -$655.58M-44.8% | -$452.63M-52.5% | -$296.79M-74.0% | -$170.6M-40.5% | ||
| $13.71M-38.9% | $22.43M— | —— | $5.84M-10.9% | ||
| $437.35M+122% | -$2.01B-152% | -$795.59M— | —— | ||
| $2.01M-99.9% | $2.45B+283% | $639.81M-25.7% | $861.55M+4,741% | ||
| -$213.77M-2,184% | -$9.36M— | —— | $765.67M+342% | ||
| -$669.29M-40.9% | -$475.05M-51.8% | -$312.85M-77.3% | -$176.44M-37.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Vaxcyte, Inc. generate?
- Vaxcyte, Inc. (PCVX) generated -$769.9M in operating cash flow over the trailing twelve months.
- What is Vaxcyte, Inc.'s free cash flow?
- After $10.4M of capital expenditures, Vaxcyte, Inc.'s free cash flow was -$780.3M over the trailing twelve months, down 61.9% year over year.
- Where does Vaxcyte, Inc.'s cash flow data come from?
- Every line is extracted from Vaxcyte, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.